drugset / Trial / NCT00157066

Summary

The purpose of this study is to determine how vitamin D supplementation (ergocalciferol) affects the immune response to mycobacterial infection.

Timeline

Start
2002-12
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 2.5 mg Oral

Indications